Consistent with this finding, the production of inflammatory cytokines such as IL-1β and IFN-γ was significantly reduced in colon tissues of the CG-598 treated group as compared to the vehicle treated colitis group (Figure 4H). The gene discussed is IL1B; the disease is colitis.